Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: A Randomized Clinical Trial.

Ellis RJ, Pugh SL, Yu JB, Feng FY, Konski AA, Grubb RL 3rd, Wallace RE, Gladstone DJ, Ménard C, Miccio JA, Frazier AJ, Pennington JD, Michalski JM, Spratt DE, Martinez A, Morgan SC, Mihai A, Solanki AA, Amjad A, Straza MW, Delouya G, Schroeder TM, Marshall DT, Kapadia N, Patel AN, Cescon TP, El-Gayed A, Yoon HA, Paulus R, Sandler HM, NRG-GU005 Collaborative Authors

Open source

DOI: 10.1001/jama.2026.12627
Published: 2026 Sep 22
Container: JAMA
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jama.2026.12627,
  title = {Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: A Randomized Clinical Trial.},
  author = {Ellis RJ and Pugh SL and Yu JB and Feng FY and Konski AA and Grubb RL 3rd and Wallace RE and Gladstone DJ and Ménard C and Miccio JA and Frazier AJ and Pennington JD and Michalski JM and Spratt DE and Martinez A and Morgan SC and Mihai A and Solanki AA and Amjad A and Straza MW and Delouya G and Schroeder TM and Marshall DT and Kapadia N and Patel AN and Cescon TP and El-Gayed A and Yoon HA and Paulus R and Sandler HM and NRG-GU005 Collaborative Authors},
  year = {2026},
  journal = {JAMA},
  doi = {10.1001/jama.2026.12627},
  url = {https://doi.org/10.1001/jama.2026.12627}
}

RIS

TY  - JOUR
TI  - Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: A Randomized Clinical Trial.
AU  - Ellis RJ
AU  - Pugh SL
AU  - Yu JB
AU  - Feng FY
AU  - Konski AA
AU  - Grubb RL 3rd
AU  - Wallace RE
AU  - Gladstone DJ
AU  - Ménard C
AU  - Miccio JA
AU  - Frazier AJ
AU  - Pennington JD
AU  - Michalski JM
AU  - Spratt DE
AU  - Martinez A
AU  - Morgan SC
AU  - Mihai A
AU  - Solanki AA
AU  - Amjad A
AU  - Straza MW
AU  - Delouya G
AU  - Schroeder TM
AU  - Marshall DT
AU  - Kapadia N
AU  - Patel AN
AU  - Cescon TP
AU  - El-Gayed A
AU  - Yoon HA
AU  - Paulus R
AU  - Sandler HM
AU  - NRG-GU005 Collaborative Authors
PY  - 2026
JO  - JAMA
DO  - 10.1001/jama.2026.12627
UR  - https://doi.org/10.1001/jama.2026.12627
ER  -

APA

RJ, E., SL, P., JB, Y., FY, F., AA, K., 3rd, G. R., RE, W., DJ, G., C, M., JA, M., AJ, F., JD, P., JM, M., DE, S., A, M., SC, M., A, M., AA, S., A, A., MW, S., G, D., TM, S., DT, M., N, K., AN, P., TP, C., A, E., HA, Y., R, P., HM, S., & Authors, N. C. (2026). Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: A Randomized Clinical Trial.. JAMA. https://doi.org/10.1001/jama.2026.12627

Source records

pubmed · retrieved 2026-09-25T17:21:37.444Z